Oculis will not pursue FDA approval for OCS-01, an eye drop for diabetic macular edema, after it failed to meet the primary ...

Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...

The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The secondary endpoint of retinal thickness showed a substantial ...

OCS-01 failed to meet the primary endpoint of improving visual acuity in both Phase 3 DIAMOND studies. ・The treatment reduced ...

P.E.I.’s health minister says he is not looking to change the province’s patient registry to prioritize finding a physician ...

Democrats are banking on a rare chance to regain ground in Iowa, while Republicans are grappling with a New Jersey ...

Across the UK, there is little doubt that the provision of healthcare in prisons has changed significantly over the last 30 ...

The evaluation, which lasted roughly three hours, was conducted just ahead of Trump’s 80th birthday and marks the fourth ...

Oculis Holding (OCS) stock plunges after late-stage trial failures for the company's lead asset, OCS-01, in diabetic macular edema. Read more here.

Nuggets from Jill Biden's memoir include an awkward car ride with Melania and a grudge with Kamala Harris.

MANCHESTER, N.H. (AP) — Former President Donald Trump easily won New Hampshire’s primary on Tuesday, seizing command of the race for the Republican nomination and making a November rematch against ...

Business travel is relentless and only growing.These seven essential business travel habits help CEOs stay healthy, sharp, ...